MRK Merck & Co., Inc.

bullish SHIFT track record → $115.46 -2.44 (-2.1%)
Mkt Cap $285B P/E 15.9 fwd 11.8 52wk $73.31 - $125.14 Earnings 2026-04-30 3h ago
Insider selling: $43,825,309 sold by 16 insiders (30d)
Est. revisions: -12.6% (3 up, 4 down in 30d)
Factor Model (net -1.7)

Factor Model

net -1.7 4.1 / 10
Est. Revisions
-0.7
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-0.3
Narrative Gap
+0.0

Merck Leads Semiconductor Precursor Market Growth

Watch: Monitor semiconductor precursor market growth and Merck's execution in this segment as a key driver for long-term valuation re-rating.

Merck holds 33% of the global semiconductor precursor market, valued at $3.534 billion in 2025 and set to double to $7.22 billion by 2032 at a 10.9% CAGR. Insider buying totals $1.58 million while insider selling exceeds $14 million, signaling mixed internal sentiment. UBS maintains a Buy rating amid strong institutional ownership despite recent share price downtrend.

Merck's dominant position in a fast-growing semiconductor precursor market offers a strong diversification avenue and revenue upside outside its core pharmaceutical business.

Evidence

3h ago Precursor for Semiconductor Market Growth Opportunities, - openPR.com google-news-semiconductor
2d ago Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy? yahoo-finance
3d ago Insider sell by ZACHARY JENNIFER L (MRK): $14,485,690
3d ago Insider buy by THULIN INGE G (MRK): $250,000
3d ago Insider buy by BAKER DOUGLAS M JR (MRK): $1,327,500
3d ago UBS main MRK: Buy → Buy
7d ago Why Terns Pharmaceuticals Stock Rocked the Market in March yahoo-finance
8d ago Strong Results Lifted Merck & Co (MRK) in Q4 yahoo-finance
7 older signals
9d ago Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho
17d ago Why is Merck & Co. (MRK) One of the Best Affordable Stocks to Buy With Good Earnings Growth?
19d ago Merck & Co. Touts $6.7B Terns Deal, Highlights TERN-701 “Best-in-Class” CML Potential
19d ago Jim Cramer on Merck & Co.: “If We’re Really Going Into an Oil Shock-Induced Slowdown, I Think This One’s Likely an Outperformer””
20d ago RBC Reiterates Merck (MRK) Outperform, Notes Investor Concerns Over “Modest Premium”
21d ago Enliven Therapeutics (ELVN) Soars to 5-Year High as Analysts ‘Upbeat’
23d ago RBC Capital Lowers its Price Target on FactSet Research Systems (FDS) to $243 from $320
Fundamentals & Data ▾
Merck & Co., Inc. Healthcare · Drug Manufacturers - General
Mkt Cap
$285B
P/E
15.9 fwd 11.8
Beta
0.28
Div Yield
288.00%
52w Range
$73.31 - $125.14
Short Interest
27.7M 1.12%
Days to Cover
2.7 -11%
Technicals downtrend
from 52w Hi
-6.3%
1w return
-5.9%
Insiders
selling 0B / 11S
Analysts
mixed
EPS Estimate
$-1.48 -12.6% 30d 3up / 4dn
Est. Dispersion
66% 17 analysts
Analyst Target
$130 $100 - $150
Options P/C
0.20 1C / 0P unusual
Insider Cluster
buy cluster 2B / 10S
Fund Convergence
strong D.E. Shaw, Citadel, Bridgewater
Financials
Revenue
$16.4B +5% YoY
FCF
$1.8B
Gross Margin
66%
Op Margin
25%
Momentum: decelerating
Top Holders
D.E. Shaw $9.1B
Citadel $1.5B
Bridgewater $33M
Recent Filings & Data
insider trade 62
net selling · $43,825,309 sold · $1,577,500 bought
16 insiders · 62 transactions (30d)
Recent transactions
GUINDO CHIRFI · sell · $1,214,562
LI DEAN Y · sell · $1,202,844
GUINDO CHIRFI · sell · $1,184,101
ZACHARY JENNIFER L · sell · $14,485,690
ZACHARY JENNIFER L · exercise · $14,485,690
WILLIAMS DAVID MICHAEL · sell · $609,525
WILLIAMS DAVID MICHAEL · exercise · $388,100
OOSTHUIZEN JOHANNES JACOBUS · sell · $1,827,992
DELUCA RICHARD ROBERT JR. · sell · $4,557,025
GUINDO CHIRFI · sell · $2,437,676
LI DEAN Y · sell · $1,791,824
LI DEAN Y · exercise · $845,475
LITCHFIELD CAROLINE · sell · $5,023,312
LITCHFIELD CAROLINE · exercise · $2,228,361
SMART DALTON E. III · sell · $765,920
SMART DALTON E. III · exercise · $248,280
DAVIS ROBERT M · sell · $5,599,327
CHATTOPADHYAY SANAT · award · $1,490,712
GUINDO CHIRFI · award · $1,059,501
ZACHARY JENNIFER L · award · $1,244,014
WILLIAMS DAVID MICHAEL · award · $656,429
LI DEAN Y · award · $2,198,371
LITCHFIELD CAROLINE · award · $1,702,505
OOSTHUIZEN JOHANNES JACOBUS · award · $539,792
LI DEAN Y · award · $3,194,901
ROMANELLI JOSEPH EDWARD · award · $612,502
SMART DALTON E. III · award · $114,488
DAVIS ROBERT M · award · $5,094,412
DELUCA RICHARD ROBERT JR. · award · $1,317,154
DOWNING CRISTAL N. · sell · $616,395
WILLIAMS DAVID MICHAEL · sell · $720,040
GUINDO CHIRFI · exercise · $2,926,039
WILLIAMS DAVID MICHAEL · exercise · $1,357,366
ROMANELLI JOSEPH EDWARD · exercise · $363,091
SMART DALTON E. III · other
SMART DALTON E. III · exercise · $170,519
LARSON BETTY D · other
SMART DALTON E. III · sell · $352,723
SMART DALTON E. III · exercise · $290,400
OOSTHUIZEN JOHANNES JACOBUS · sell · $714,745
WILLIAMS DAVID MICHAEL · sell · $512,057
OOSTHUIZEN JOHANNES JACOBUS · other
DOWNING CRISTAL N. · sell · $209,551
THULIN INGE G · buy · $250,000
BAKER DOUGLAS M JR · buy · $1,327,500
CHATTOPADHYAY SANAT · award · $2,755,640
GUINDO CHIRFI · award · $2,757,795
ZACHARY JENNIFER L · award · $2,489,929
WILLIAMS DAVID MICHAEL · award · $1,003,493
LITCHFIELD CAROLINE · award · $2,294,930
DOWNING CRISTAL N. · award · $925,141
OOSTHUIZEN JOHANNES JACOBUS · award · $848,552
SMART DALTON E. III · award · $253,273
DAVIS ROBERT M · award · $9,331,234
DELUCA RICHARD ROBERT JR. · award · $2,491,398
GUINDO CHIRFI · exercise · $4,250,995
KLOBUCHAR MICHAEL A · exercise · $113,101
OOSTHUIZEN JOHANNES JACOBUS · other
SMART DALTON E. III · other
DELUCA RICHARD ROBERT JR. · other
ROMANELLI JOSEPH EDWARD · other
SMART DALTON E. III · exercise · $49,073
15 signals · latest 3h ago

Get alerted when MRK changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.

All stocks → Our calls → How it works →